Clindamycin and Tocilizumab: Interaction Details
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Clindamycin and Tocilizumab interaction:
Clindamycin
- Cleocin
- Clindacin
- Xaciato
- Clindagel
- Clindamax
- Clindesse
- Cleocin-T
- Cleocin Phosphate
- Cleocin Hydrochloride
- Clindacin P
- Clindacin ETZ
- Cleocin T
- Cleocin Pediatric
Tocilizumab
- Actemra
- Avtozma
- Tofidence
- Tyenne
We don't have a drug information page for Tocilizumab yet. Have a question about Tocilizumab? Ask a pharmacist, free →
What Happens When You Take Clindamycin With Tocilizumab
What can happen when they are taken together (rated Major)
Reduced with NTI exposure and reduced of CYP3A4 substrate with NTI
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Taking tocilizumab together with a CYP3A4 substrate that has a (NTI) can lower the substrate's exposure. Clinical trials demonstrated that CYP3A4 substrates (omeprazole, simvastatin, and dextromethorphan) had reduced exposure one week after a single tocilizumab dose.
For patients receiving a CYP3A4 NTI substrate, monitor the therapeutic response or drug levels and adjust the individual dose of that substrate as needed when tocilizumab is started or stopped. Tocilizumab's impact on enzyme activity can continue for several weeks following discontinuation of the drug. Exercise caution when giving tocilizumab alongside CYP3A4 substrate medications such as oral contraceptives, lovastatin, atorvastatin, and others, where a loss of effectiveness would be undesirable.123
The Clindamycin and Tocilizumab Interaction, Explained
Here's what's going on. Tocilizumab (Actemra) can calm down inflammation in your body, and when it does, it can speed up a liver enzyme called . Clindamycin is partly broken down by that same enzyme. So when you use both, your body may clear clindamycin a little faster, which could make the antibiotic less effective at fighting your infection.
The good news is this is manageable. Your care team can watch how well your infection is responding and adjust things if needed. Don't stop or change either medicine on your own. Just let your pharmacist or doctor know you take both so they can keep an eye on how you're doing.
Mechanism: Tocilizumab normalizes IL-6-mediated suppression of , effectively inducing CYP3A4 activity. Clindamycin is a CYP3A4 , so may increase its and reduce systemic exposure, potentially lowering antibacterial .
- Direction: reduced clindamycin exposure / effect ()
- Evidence: probable; documented decreases in omeprazole, simvastatin, dextromethorphan after a single tocilizumab dose
- Onset: develops over ~1 week; effect may persist several weeks after discontinuation
- Management: monitor therapeutic response (clinical resolution of infection); consider dose or regimen adjustment individualized by the team on initiation/discontinuation of tocilizumab
See the 3 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Clindamycin and Tocilizumab Interact
The likely mechanism
of -mediated by tocilizumab
How to Manage the Clindamycin and Tocilizumab Interaction
Keep taking both as prescribed unless your care team tells you otherwise.
- Your team may watch more closely to make sure the clindamycin is working and your infection is improving.
- The clindamycin dose or regimen may need to be adjusted and individualized by your care team, especially when tocilizumab is started or stopped.
- Remember this effect can last for several weeks after tocilizumab is stopped, so timing matters.
- Tell your pharmacist or prescriber if your infection is not getting better or seems to be coming back.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Clindamycin or Tocilizumab need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: AVTOZMA intravenous, subcutanous injection, tocilizumab-anoh intravenous, subcutanous injection
-
Report 2 · Study title
Prescribing information: TYENNE intravenous, subcutaneous injection, tocilizumab-aazg intravenous, subcutaneous injection
In drug interaction studies involving 13 RA patients given 30 mg dextromethorphan (a of and ), dextromethorphan exposure was similar to that seen in healthy subjects. Exposure to its dextrorphan (a CYP3A4 substrate), however, was only a portion of what was observed in healthy subjects.
One week after a single infusion of tocilizumab (8 mg per kg), dextromethorphan exposure fell by roughly 5%. A greater reduction (29%) in dextrorphan levels was observed following the tocilizumab infusion.2
Clindamycin and Tocilizumab: Common Questions
How serious is the Clindamycin and Tocilizumab interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Clindamycin and Tocilizumab interaction managed?
Keep taking both as prescribed unless your care team tells you otherwise. Your team may watch more closely to make sure the clindamycin is working and your infection is improving. The clindamycin dose or regimen may need to be adjusted and individualized by your care team, especially when tocilizumab is started or stopped. Remember this effect can last for several weeks after tocilizumab is stoppe… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Clindamycin and Tocilizumab Interaction
Ask in your own words about taking Clindamycin and Tocilizumab together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (3)
- Product Information: AVTOZMA(R) intravenous, subcutanous injection, tocilizumab-anoh intravenous, subcutanous injection. CELLTRION USA, Inc. Jersey City, NJ, 2025. DailyMed
- Product Information: TYENNE(R) intravenous, subcutaneous injection, tocilizumab-aazg intravenous, subcutaneous injection. Fresenius Kabi USA, LLC (Per FDA), Lake Zurich, IL, 2024. DailyMed
- Product Information: TOFIDENCE(TM) intravenous injection, tocilizumab-bavi intravenous injection. Biogen MA Inc (per FDA), Cambridge, MA, 2023. DailyMed
Other Serious Interactions of Clindamycin and Tocilizumab
Also serious with Clindamycin
- LevoketoconazoleContraindicated
- Mifepristone (Korlym)Contraindicated
- Mifepristone (Mifeprex)Contraindicated
- ApalutamideMajor
Also serious with Tocilizumab
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Clindamycin
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 166 more
With Tocilizumab
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin AModerate
- SeleniumModerate
- TurmericModerate
- Green TeaModerate
- AshwagandhaModerate
- + 81 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.